Hualan Biological Engineering Inc. (SHE:002007)
China flag China · Delayed Price · Currency is CNY
11.73
+0.05 (0.43%)
Nov 17, 2026, 3:04 PM CST

SHE:002007 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,080774.811,367993.771,099692.54
Short-Term Investments
1,9881,0052,1441,213240-
Trading Asset Securities
2,3072,6231,8882,1152,3692,659
Cash & Short-Term Investments
5,3754,4035,3984,3223,7083,352
Cash Growth
-0.73%-18.44%24.90%16.56%10.63%-16.72%
Accounts Receivable
1,6782,0782,0522,5902,4102,097
Other Receivables
2.646.0918.666.954.847.05
Receivables
1,6812,0842,0713,2972,7592,104
Inventory
2,8002,2892,0291,6741,4471,359
Other Current Assets
513.283.78118.4633.7163.5636.67
Total Current Assets
10,3698,8599,6169,3278,0776,851
Property, Plant & Equipment
2,8962,9822,9642,7272,2902,338
Long-Term Investments
245.292,7843,0233,2733,6731,716
Goodwill
---1.11.11.1
Other Intangible Assets
310.18314.13319.04319.72310204.53
Long-Term Deferred Tax Assets
214.58196.85235.34241.72232.49201.25
Long-Term Deferred Charges
51.7355.3159.6959.642.4955.42
Other Long-Term Assets
629.5869.7992.74157.3116.8170.16
Total Assets
14,71615,26216,31016,10614,74311,537

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
211.32196.26217.16197.26175.49241.03
Accrued Expenses
0.45926.54914.991,1691,071947.5
Short-Term Debt
600447899.73700.35800.38800.7
Current Portion of Long-Term Debt
---300-10.18
Current Portion of Leases
0.390.390.370.360.44-
Current Income Taxes Payable
79.2218.1419.5863.369.748.71
Current Unearned Revenue
21.0610.2113.468.5714.788.28
Other Current Liabilities
1,336196.78294.83142.376.53158.53
Total Current Liabilities
2,2481,7952,3602,5812,1482,215
Long-Term Debt
----300190
Long-Term Leases
7.978.398.789.159.3-
Long-Term Unearned Revenue
71.1759.4654.1851.1854.3757.91
Long-Term Deferred Tax Liabilities
35.748.1140.1442.8220.8710.37
Total Liabilities
2,3631,8712,4632,6852,5332,473

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
1,8261,8271,8291,8291,8241,824
Additional Paid-In Capital
1,3811,3971,4301,4861,415105.62
Retained Earnings
7,4478,2948,6338,0937,1596,448
Treasury Stock
--17.95-32.72-48.07--40.59
Total Common Equity
10,65411,50111,85911,35910,3988,337
Minority Interest
1,6991,8901,9882,0621,812727.09
Shareholders' Equity
12,35313,39113,84713,42112,2109,064
Total Liabilities & Equity
14,71615,26216,31016,10614,74311,537

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
608.36455.78908.881,0101,1101,001
Net Cash (Debt)
4,7673,9474,4893,3122,5982,351
Net Cash Growth
-3.88%-12.07%35.54%27.50%10.51%-35.14%
Net Cash Per Share
2.612.162.461.821.421.28
Filing Date Shares Outstanding
1,8261,8271,8291,8291,8241,824
Total Common Shares Outstanding
1,8261,8271,8291,8291,8241,824
Working Capital
8,1207,0647,2566,7455,9294,636
Book Value Per Share
5.846.296.486.215.704.57
Tangible Book Value
10,34411,18611,54011,03910,0878,131
Tangible Book Value Per Share
5.676.126.316.045.534.46
Buildings
-1,8081,7171,3021,2061,256
Machinery
-2,7142,6392,5042,3832,433
Construction In Progress
-643.37552.48661.51216.39132.96